CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 0-402 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/cb16d307afaecebd683e6d74c8b501ed54b0c9a4","sourcedb":"CORD-19","sourceid":"cb16d307afaecebd683e6d74c8b501ed54b0c9a4","text":"Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect\n\nAbstract\nThe pyrazolone structural motif is a critical element of drugs aimed at different biological end-points. Medicinal chemistry researches have synthesized drug-like pyrazolone candidates with several medicinal features including antimicrobial, antitumor, CNS (central nervous system) effect, anti-inflammatory activiti","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":51},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":52,"end":75},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":77,"end":85},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":86,"end":190},"obj":"Sentence"},{"id":"T49590","span":{"begin":0,"end":51},"obj":"Sentence"},{"id":"T49709","span":{"begin":52,"end":75},"obj":"Sentence"},{"id":"T96525","span":{"begin":77,"end":85},"obj":"Sentence"},{"id":"T7325","span":{"begin":86,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T2","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T3","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T4","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T49590","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T49709","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T96525","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T7325","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-PICO","denotations":[{"id":"p1_all0","span":{"begin":0,"end":27},"obj":"Intervention"},{"id":"p2_i0","span":{"begin":0,"end":10},"obj":"Pharmacological"},{"id":"p2_i1","span":{"begin":249,"end":259},"obj":"Pharmacological"}],"attributes":[{"subj":"p1_all0","pred":"source","obj":"CORD-PICO"},{"subj":"p2_i0","pred":"source","obj":"CORD-PICO"},{"subj":"p2_i1","pred":"source","obj":"CORD-PICO"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T1","span":{"begin":0,"end":51},"obj":"Sentence"},{"id":"T2","span":{"begin":52,"end":75},"obj":"Sentence"},{"id":"T3","span":{"begin":77,"end":85},"obj":"Sentence"},{"id":"T4","span":{"begin":86,"end":190},"obj":"Sentence"}],"attributes":[{"subj":"T1","pred":"source","obj":"CORD-19_Custom_license_subset"},{"subj":"T2","pred":"source","obj":"CORD-19_Custom_license_subset"},{"subj":"T3","pred":"source","obj":"CORD-19_Custom_license_subset"},{"subj":"T4","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1","span":{"begin":344,"end":366},"obj":"Body_part"},{"id":"T2","span":{"begin":352,"end":366},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"},{"subj":"T1","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T2","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93a1ec","default":true},{"id":"CORD-PICO","color":"#bbec93"},{"id":"CORD-19_Custom_license_subset","color":"#ec93d5"},{"id":"CORD-19-PD-UBERON","color":"#93ece9"}]}]}}